跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BENDAMUSTINE GEN bendamustine hydrochloride 25 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
BENDAMUSTINE GEN bendamustine hydrochloride 25 mg powder for injection vial
Approved
STANDARD
BENDAMUSTINE GEN bendamustine hydrochloride 25 mg powder for injection vial
Luminarie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
5528ed3178a968ab
Company
Luminarie Pty Ltd
Type
Standard
Approval Details
Approval Id
5528ed3178a968ab
Product Name
BENDAMUSTINE GEN bendamustine hydrochloride 25 mg powder for injection vial
Artg Id
321007
Artg Name
BENDAMUSTINE GEN bendamustine hydrochloride 25 mg powder for injection vial
Sponsor
Luminarie Pty Ltd
Company Detail Path
/organization/luminarie-pty-ltd
Artg Date
2020-09-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
5528ed3178a968ab
Type
Standard
Back to TGA Approvals
